Central serous chorioretinopathy complicating systemic corticosteroid therapy.
OBJECTIVE
To present evidence that systemic corticosteroid therapy may cause central serous chorioretinopathy.


METHODS
A 20-year-old male with idiopathic thrombocytopenic purpura was examined during systemic treatment with corticosteroids (100 mg daily).


RESULTS
The patient had central serous chorioretinopathy. Spontaneous recovery accompanied discontinuation of the steroid treatment.


CONCLUSIONS
This case provides further evidence that cortisol may play a role in the development of central serous chorioretinopathy.
Abu el-Asrar
A M
AM
Department of Ophthalmology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
D000328:Adult; D015862:Choroid Diseases / Q000139:chemically induced* / Q000473:pathology / Q000503:physiopathology; D005122:Exudates and Transudates; D005451:Fluorescein Angiography; D005654:Fundus Oculi; D005938:Glucocorticoids / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D011241:Prednisone / Q000009:adverse effects* / Q000627:therapeutic use; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000188:drug therapy; D012075:Remission, Spontaneous; D012164:Retinal Diseases / Q000139:chemically induced* / Q000473:pathology / Q000503:physiopathology
D005938:Glucocorticoids; D011241:Prednisone